查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫用大麻市場規模、份額和趨勢分析：按產品類型、應用和地區劃分的細分市場預測（2022-2030 年）
市場調查報告書
商品編碼
1092449

全球醫用大麻市場規模、份額和趨勢分析：按產品類型、應用和地區劃分的細分市場預測（2022-2030 年）

Medical Marijuana Market Size, Share & Trends Analysis Report By Product Type (Flower, Oil & Tinctures), Application (Chronic Pain, Arthritis, Migraine, Cancer, Diabetes, AIDS, Epilepsy, Parkinson's Disease), Region, & Segment Forecasts, 2022-2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

預計從 2022 年到 2030 年，全球醫用大麻市場將以 21.6% 的複合年增長率增長，到 2030 年將達到 659 億美元。

越來越多的州和國家批准用於治療用途是推動未來幾年需求的關鍵因素之一。一些監管框架的存在，例如醫用大麻監管和安全立法，是當前市場對藥品需求的指標。發牌數量的增加也被認為是市場的驅動因素之一。

本報告調查全球醫用大麻市場，並提供市場概況、市場規模趨勢和按產品類型/用途/地區預測、競爭形勢和主要公司概況等信息。

目錄

第一章調查方法及範圍

第2章執行摘要

第 3 章市場變量、趨勢、範圍

  • 滲透/增長前景映射
  • 產品管線分析：分階段
  • 技術概述
  • 監管框架
  • 市場動態
  • 醫用大麻市場分析工具

第 4 章醫用大麻市場估計和趨勢分析：按產品類型

  • 定義和範圍
  • 醫用大麻市場份額：按產品類型
  • 細分儀表板
  • 花
  • 油酊

第 5 章醫用大麻市場估計和趨勢分析：按用途

  • 定義和範圍
  • 醫用大麻市場份額：按應用
  • 細分儀表板
  • 癌症
  • 慢性疼痛
  • 抑鬱/焦慮
  • 關節炎
  • 糖尿病
  • 青光眼
  • 偏頭痛
  • 癲癇
  • 多發性硬化症
  • 艾滋病
  • 肌萎縮側索硬化症
  • 阿爾茨海默病
  • 創傷後應激障礙 (PTSD)
  • 帕金森病
  • 妥瑞
  • 其他

第 6 章醫用大麻市場估計和趨勢分析：按地區、按產品

  • 市場規模/預測、趨勢分析（2017-2030）

第7章競爭態勢

  • 公司簡介
    • Tilray
    • Aurora Cannabis
    • Canopy Growth Corporation
    • Aphria, Inc.
    • Maricann Group, Inc.
    • Tikun Olam, Ltd.
    • MedReleaf. Corp.
    • GW Pharmaceuticals plc.
    • Cannabis Sativa, Inc.
    • Medical Marijuana, Inc.
Product Code: GVR-1-68038-754-4

Medical Marijuana Market Growth & Trends:

The global medical marijuana market size is expected to reach USD 65.8 billion by 2030 and is expected to expand at a CAGR of 21.6% over the forecast period, according to a new report by Grand View Research, Inc. The major factors attributed to the industry growth are the rapid adoption of cannabis in therapeutic applications and a surge in the number of countries legalizing the usage of medical marijuana.

As per numerous studies, cannabis has shown positive results in the treatment of chronic diseases. Thus, with the growing penetration of chronic disease throughout the globe, the industry is expected to see a steep rise in demand. For instance, as per the data released by the WHO, the chronic disease burden was expected to reach 57% by 2020. The growing research and development activities in the industry are also expected to drive the growth in demand.

Additionally, various factors such as a rise in disposable income, increasing social acceptance of cannabis, and growth in awareness regarding the benefits of the product, along with improvements in intellectual property rights of cannabis are some of the major factors that are expected to fuel the growth of the industry.

Key players are coming together on strategic initiatives such as mergers & acquisitions, collaborations, partnerships, funding & investments, and innovative product developments & launches to expand their expertise & product portfolio. This also fuels the industry's growth. For instance, in March 2021, Germany's largest pharmaceutical company, Stada entered the medical marijuana market by launching its two flower products, and further, the company has plans to offer five flower products along with three extracts with different compositions of CBD and THC.

One of the major factors that restrict industry growth is the strict regulation policy. To date, FDA has not allowed the marketing usage of cannabis for the treatment of any disease or condition. Although, the organization has approved one cannabis-derived drug product: Epidiolex (cannabidiol), and three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). These permitted drug products are only available with a prescription from a licensed healthcare provider.

Medical Marijuana Market Report Highlights:

  • The market size is anticipated to be valued at USD 65.8 million by 2030, owing to the growing legalization of medical marijuana in various countries
  • In 2021, the oil and tinctures segment dominated the market owing to its growing medical usage for the treatment of chronic pains, cancer, neurological disorders, and others
  • Chronic pain segment dominated in 2021. The growing number of clinical trials with marijuana to treat neuropathic and chronic pain is one of the key indicators, which highlights the rising usage of cannabis in pain management over the coming few years
  • North America dominated in 2021 owing to the presence of major players, the increasing rate of cannabis legalization in the U.S., and the launch of new products

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources & Third Party perspectives
    • 1.3.4 Primary Research
  • 1.4 Information Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Medical Marijuana Market Outlook, By Revenue (USD Million)

Chapter 3 Medical Marijuana Market Variables, Trends and Scope

  • 3.1 Penetration & Growth Prospect Mapping
  • 3.2 Product Pipeline Analysis, by Stage
  • 3.3 Technology Overview
    • 3.3.1 Technology timeline
  • 3.4 Regulatory Framework
  • 3.5 Market Dynamics
    • 3.5.1 Market driver analysis
    • 3.5.2 Market restraint analysis
  • 3.6 Medical Marijuana Market Analysis Tools
    • 3.6.1 Industry analysis - Porter's
      • 3.6.1.1 Supplier power
      • 3.6.1.2 Buyer power
      • 3.6.1.3 Substitution threat
      • 3.6.1.4 New entrants threat
      • 3.6.1.5 Competitive rivalry
    • 3.6.2 PESTEL Analysis
      • 3.6.2.1 Political landscape
      • 3.6.2.2 Economic landscape
      • 3.6.2.3 Social landscape
      • 3.6.2.4 Technology landscape
    • 3.6.3 Global Marijuana Demand-Supply Analysis
    • 3.6.4 Global Marijuana Trade Route
    • 3.6.5 Patient Pool Analysis

Chapter 4 Medical Marijuana Market: Product Type Estimates & Trend Analysis

  • 4.1 Definitions & Scope
  • 4.2 Medical Marijuana Market Share by Product Type
  • 4.3 Segment Dashboard
  • 4.4 Flower
    • 4.4.1 Flower market estimates and forecasts, 2017 - 2030 (USD Million)
  • 4.5 Oil & Tinctures
    • 4.5.1 Oil & tinctures market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 5 Medical Marijuana Market: Application Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Medical Marijuana Market Share by Application
  • 5.3 Segment Dashboard
  • 5.4 Cancer
    • 5.4.1 Cancer market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.5 Chronic Pain
    • 5.5.1 Chronic pain market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.6 Depression & Anxiety
    • 5.6.1 Depression & anxiety market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.7 Arthritis
    • 5.7.1 Arthritis market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.8 Diabetes
    • 5.8.1 Diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.9 Glaucoma
    • 5.9.1 Glaucoma market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.10 Migraines
    • 5.10.1 Migraines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.11 Epilepsy
    • 5.11.1 Epilepsy market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.12 Multiple Sclerosis
    • 5.12.1 Multiple Sclerosis market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.13 AIDS
    • 5.13.1 AIDS market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.14 Amyotrophic Lateral Sclerosis
    • 5.14.1 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.15 Alzheimer's Disease
    • 5.15.1 Alzheimer's Disease market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.16 Post-Traumatic Stress Disorder (PTSD)
    • 5.15.1 Post-Traumatic Stress Disorder (PTSD)market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.17 Parkinson's Disease
    • 5.17.1 Parkinson's Disease market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.18 Tourettes
    • 5.18.1 Tourettes market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.19 Others
    • 5.19.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 6 Medical Marijuana Market: Regional Estimates & Trend Analysis, by Product

  • 6.1 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030:
    • 6.1.1 U.S.
      • 6.1.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.1.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.2.1 Canada
      • 6.2.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.2.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.3.1 Germany
      • 6.3.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.3.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.4.1 U.K.
      • 6.4.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.4.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.5.1 Italy
      • 6.5.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.5.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.6.1 Poland
      • 6.6.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.6.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.7.1 Czech Republic
      • 6.7.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.7.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.8.1 Switzerland
      • 6.8.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.8.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.9.1 Croatia
      • 6.9.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.9.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.10.1 Netherlands
      • 6.10.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.10.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.11.1 Spain
      • 6.11.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.11.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.12.1 China
      • 6.12.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.12.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.13.1 Japan
      • 6.13.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.13.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.14.1 India
      • 6.14.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.14.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.15.1 Thailand
      • 6.15.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.15.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.16.1 Australia
      • 6.16.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.16.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.17.1 New Zealand
      • 6.17.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.17.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.18.1 Uruguay
      • 6.18.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.18.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.19.1 Colombia
      • 6.19.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.19.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.20.1 Brazil
      • 6.20.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.20.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.21.1 Mexico
      • 6.21.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.21.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)
    • 6.22.1 Africa
      • 6.22.1.1 Market estimates and forecasts, by product type, 2017 - 2030 (USD Million)
      • 6.22.1.2 Market estimates and forecasts, by application 2017 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Profiles
    • 7.1.1 Tilray
      • 7.1.1.1 Company Overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Product Benchmarking
      • 7.1.1.4 Strategic Initiatives
    • 7.1.2 Aurora Cannabis
      • 7.1.2.1 Company Overview
      • 7.1.2.2 Financial Performance
      • 7.1.2.3 Product Benchmarking
      • 7.1.2.4 Strategic Initiatives
    • 7.1.3 Canopy Growth Corporation
      • 7.1.3.1 Company Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Product Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 Aphria, Inc.
      • 7.1.4.1 Company Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Product Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 Maricann Group, Inc.
      • 7.1.5.1 Company Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Product Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 Tikun Olam, Ltd.
      • 7.1.6.1 Company Overview
      • 7.1.6.2 Financial Performance
      • 7.1.6.3 Product Benchmarking
      • 7.1.6.4 Strategic Initiatives
    • 7.1.7 MedReleaf. Corp.
      • 7.1.7.1 Company Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Product Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 GW Pharmaceuticals plc.
      • 7.1.8.1 Company Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Product Benchmarking
      • 7.1.8.4 Strategic Initiatives
    • 7.1.9 Cannabis Sativa, Inc.
      • 7.1.9.1 Company Overview
      • 7.1.9.2 Financial Performance
      • 7.1.9.3 Product Benchmarking
      • 7.1.9.4 Strategic Initiatives
    • 7.1.10 Medical Marijuana, Inc.
      • 7.1.10.1 Company Overview
      • 7.1.10.2 Financial Performance
      • 7.1.10.3 Product Benchmarking
      • 7.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 U.S. medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 2 U.S. medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 3 Canada medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 4 Canada medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 5 Germany medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 6 Germany medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 7 U.K. medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 8 U.K. medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 9 Italy medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 10 Italy medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 11 Poland medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 12 Poland medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 13 Czech Republic medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 14 Czech Republic medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 15 Switzerland medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 16 Switzerland medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 17 Croatia medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 18 Croatia medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 19 Netherlands medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 20 Netherlands medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 21 Spain medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 22 Spain medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 23 China medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 24 China medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 25 Japan medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 26 Japan medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 27 India medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 28 India medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 29 Thailand medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 30 Thailand medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 31 Australia medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 32 Australia medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 33 New Zealand medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 34 New Zealand medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 35 Uruguay medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 36 Uruguay medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 37 Colombia medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 38 Colombia medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 39 Brazil medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 40 Brazil medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 41 Mexico medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 42 Mexico medical marijuana market, by Application 2017 - 2030 (USD Million)
  • Table 43 Africa medical marijuana market, by Product Type 2017 - 2030 (USD Million)
  • Table 44 Africa medical marijuana market, by Application 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Medical marijuana market variables, trends & scope
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Product Type market share analysis
  • Fig. 14 Segment Dashboard
  • Fig. 15 Flower market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 16 Oil & tinctures market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 17 Application market share analysis
  • Fig. 18 Segment Dashboard
  • Fig. 19 Chronic Pain market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 20 Mental Disorders market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 21 Cancer market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 23 Regional market snapshot
  • Fig. 24 Regional outlook
  • Fig. 25 U.S. Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 26 Canada Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 27 Germany Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 28 U.K. Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 29 Italy Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 30 Poland Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 31 Czech Republic Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 32 Switzerland Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 33 Croatia Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 34 Netherlands Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 35 Spain Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 36 China Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 37 Japan Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 38 India Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 39 Thailand Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 40 Australia Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 41 New Zealand Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 42 Uruguay Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 43 Colombia Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 44 Brazil Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 45 Mexico Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 46 Africa Medical marijuana market estimates and forecasts, 2017 - 2030 (USD Million)